Renalytix (RENX) Stock Chart & Stock Price History GBX 8.15 -0.35 (-4.12%) As of 05/22/2025 11:54 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Renalytix Stock Price Performance The Renalytix (RENX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 58.21%, with a year-to-date return of -25.91%. In the past month, the stock has decreased 4.12%, reflecting recent market activity. As of the latest close, Renalytix traded at GBX 8.15 with a market cap of £33.78 million and volume of 488,777 shares. Five years ago, the stock traded at GBX 420, representing a 98.06% decrease over that period. At the time, it had a market cap of £263.21 million and a volume of 18,333 shares. Receive RENX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.12%1 Month Performance-4.12%3 Month Performance-25.91%Year-To-Date Performance-25.91%1 Year Performance-58.21%5 Year Performance-98.06% RENX Stock Chart for Friday, May, 23, 2025 RENX Chart by TradingView Renalytix Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025GBX 8GBX 8.15+1.88%GBX 8.40GBX 8488,777 shs£33.78 million05/21/2025GBX 8GBX 8GBX 9GBX 865,945 shs£33.16 million05/20/2025GBX 8GBX 8GBX 9GBX 8294,312 shs£33.16 million05/19/2025GBX 8.50GBX 8-5.88%GBX 8.28GBX 82,360 shs£33.16 million05/16/2025GBX 8.01GBX 8.50+6.12%GBX 8.50GBX 8.3034,384 shs£35.24 million05/15/2025GBX 8.01GBX 8.01GBX 8.25GBX 8.012,623 shs£33.20 million05/14/2025GBX 8.50GBX 8.01-5.76%GBX 8.50GBX 8.017,477 shs£33.20 million05/13/2025GBX 8GBX 8.50+6.25%GBX 8.50GBX 8.25118 shs£35.24 million05/12/2025GBX 8GBX 8GBX 8.50GBX 8105,176 shs£33.16 million05/09/2025GBX 8.05GBX 8-0.62%GBX 8.40GBX 8197,023 shs£33.16 million Get the Latest News and Ratings for RENX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025GBX 8.40GBX 8.05-4.17%GBX 8.05GBX 862,576 shs£33.37 million05/07/2025GBX 8GBX 8.40+5.00%GBX 8.40GBX 8109,854 shs£34.82 million05/06/2025GBX 8.20GBX 8-2.44%GBX 8.50GBX 7.50231,215 shs£33.16 million05/05/2025GBX 8.20GBX 8.20GBX 8.45GBX 7.50161,061 shs£33.99 million05/02/2025GBX 8.50GBX 8.20-3.53%GBX 8.45GBX 7.50161,061 shs£33.99 million05/01/2025GBX 8.50GBX 8.50GBX 8.50GBX 842 shs£35.24 million04/30/2025GBX 8GBX 8.50+6.25%GBX 8.50GBX 842 shs£35.24 million04/29/2025GBX 7.68GBX 8+4.17%GBX 8.50GBX 865,118 shs£33.16 million04/28/2025GBX 8.40GBX 7.68-8.57%GBX 8.50GBX 7.68287 shs£31.84 million04/25/2025GBX 8.39GBX 8.40+0.12%GBX 8.40GBX 7.5073,993 shs£34.82 million04/24/2025GBX 8.50GBX 8.39-1.29%GBX 8.39GBX 8554 shs£34.78 million04/23/2025GBX 7.50GBX 8.50+13.33%GBX 8.50GBX 8.401,308 shs£35.24 million04/22/2025GBX 8GBX 7.50-6.25%GBX 8GBX 7.5014,763 shs£31.09 million Related Companies Kooth Stock Chart Cambridge Cognition Stock Chart Induction Healthcare Group Stock Chart Feedback Stock Chart Trellus Health Stock Chart IQ-AI Stock Chart Craneware Stock Chart hVIVO Stock Chart EKF Diagnostics Stock Chart Diaceutics Stock Chart Receive RENX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. This page (LON:RENX) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Renalytix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RENX Stock Free RENX Stock Alerts